Clinical Trials Browser

Phase 1/2 × Advanced Cancer × regorafenib × Clear all

NCT03994601 2026-01-20

An Investigational Immunotherapy Study of BMS-986288 Alone and in Combination With Nivolumab in Advanced Solid Cancers

Phase 1/2 Completed

219 enrolled 35 charts

Advanced Cancer